ClinVar Miner

Submissions for variant NM_001367624.2(ZNF469):c.5613_5622del (p.Arg1871fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003230962 SCV003929211 likely pathogenic Brittle cornea syndrome 1 2023-04-04 criteria provided, single submitter clinical testing Variant summary: ZNF469 c.5613_5622del10 (p.Arg1871SerfsX25) results in a premature termination codon and is predicted to cause a truncation of the encoded protein. Although the variant is not predicted to cause absence of the protein through nonsense mediated decay, the variant disrupts the last ~2000 amino acids in the protein sequence, which is greater than half of the total protein. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.7554del [p.Ser2519Alafs], c.8350C>T [p.Arg2784Ter]). The variant was absent in 151752 control chromosomes (gnomAD). To our knowledge, no occurrence of c.5613_5622del10 in individuals affected with Brittle Cornea Syndrome 1 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.